Skip to main content

Table 1 (abstract A31). Change in HRQOL and Disability Within 3 Months of Starting Therapy in sJIA Patients*

From: Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

Variable

Placebo

n = 37

Tocilizumab

n = 75

Difference

Baseline

Week 12

Baseline

Week 12

At Week 12

In Change From Baseline to Week 12‡

CHAQ-DI

1.66 (0.82)

1.17 (0.99)

1.74 (0.79)

0.94 (0.77)

–0.23

–0.31 (–0.62, 0.00)

 Activity

1.86 (1.00)

1.30 (1.18)

1.93 (0.99)

1.19 (1.11)

–0.11

–0.18 (–0.61, 0.25)

 Rising

1.51 (0.96)

1.00 (1.08)

1.55 (0.93)

0.79 (0.92)

–0.21

–0.25 (–0.67, 0.18)

 Dressing and grooming

1.84 (1.09)

1.27 (1.19)

1.91 (1.02)

1.18 (1.00)

–0.09

–0.16 (–0.54, 0.22)

 Eating

1.22 (1.18)

0.89 (1.02)

1.49 (1.06)

0.64 (0.76)

–0.25

–0.53 (–0.96, –0.09)

 Grip

1.65 (1.03)

1.11 (1.10)

1.81 (0.91)

0.97 (1.00)

–0.13

–0.3 (–0.73, 0.13)

 Hygiene

1.69 (1.04)

1.19 (1.17)

1.75 (1.00)

0.96 (1.08)

–0.23

–0.29 (–0.71, 0.14)

 Reach

1.89 (1.05)

1.46 (1.14)

1.95 (0.96)

1.04 (0.94)

–0.42†

–0.47 (–0.86, –0.08)

 Walking

1.62 (0.92)

1.11 (1.07)

1.52 (0.98)

0.76 (0.96)

–0.35

–0.25 (–0.62, 0.12)

VAS

 Pain-global

53.51 (22.35)

28.19 (27.17)

61.4 (23.98)

22.33 (24.21)

–5.86

–13.74 (–25.92, –1.56)

 Physician-global

61.35 (21.12)

25.49 (24.01)

69.63 (15.65)

21.75 (19.20)

–3.74

–12.02 (–21.52, –2.51)

 Patient-global

56.27 (21.2)

29.38 (25.93)

60.28 (23.78)

21.29 (21.88)

–8.09

–12.09 (–23.36, –0.83)

CHQ

 Global health

37.43 (28.06)

51.56 (21.98)

30.54 (25.66)

59.51 (26.57)

7.95

13.79 (0.34, 27.23)

 Physical function

34.98 (25.56)

56.16 (34.18)

35.04 (27.78)

69.02 (29.56)

12.86

16.75 (4.16, 29.34)

 Role/social limitation-physical

42.13 (30.21)

66.16 (35.47)

41.11 (33.37)

80.32 (26.59)

14.16†

16.2 (0.23, 32.18)

 Role/social limitation-emotional

51.54 (34.24)

69.7 (34.5)

53.04 (34.20)

82.72 (25.49)

13.02

15.43 (–1.04, 31.91)

 Pain/discomfort

34.72 (19.93)

54.85 (28.63)

30.27 (21.12)

65.56 (26.10)

10.71

15.94 (4.41, 27.46)

 Behavior

64.00 (14.74)

61.36 (15.98)

63.72 (12.23)

69.12 (12.12)

7.76†

7.20 (1.75, 12.64)

 Mental health

59.97 (15.65)

66.36 (17.91)

63.07 (19.12)

75.14 (17.58)

8.78†

5.64 (–1.62, 12.9)

 Self-esteem

61.76 (20.91)

69.72 (23.7)

60.56 (20.92)

74.98 (18.81)

5.25

8.16 (–0.29, 16.61)

 General health

41.76 (13.85)

45.08 (13.48)

42.20 (14.43)

39.96 (14.97)

–5.11

–4.59 (–10.19, 1.01)

 Parental emotional

38.43 (20.44)

52.78 (26.24)

39.44 (25.24)

62.38 (25.64)

9.61

10.16 (–0.76, 21.07)

 Parental time

57.72 (26.54)

69.02 (23.2)

60.59 (28.73)

72.99 (29.12)

3.97

2.08 (–10.83, 15)

 Family activity

50.67 (22.26)

65.03 (23.87)

59.72 (23.92)

75.02 (25.51)

10

3.60 (–6.21, 13.41)

 Family cohesion

75.97 (19.92)

69.24 (26.70)

70.33 (23.81)

75.56 (22.21)

6.31

10.66 (2.38, 18.94)

 CHQ-PhS

19.47 (12.85)

31.85 (17.02)

18.68 (13.84)

36.97 (13.99)

5.12

7.31 (1.13, 13.49)

 CHQ-PsS

40.64 (8.61)

43.57 (11.33)

41.38 (11.45)

48.44 (9.29)

4.87†

4.85 (0.42, 9.27)

  1. *Data are mean (SD) unless otherwise specified. †ANOVA, p < 0.05. ‡Median (min, max). ANOVA, analysis of variance; CHAQ-DI, Childhood Health Assessment Questionnaire–Disability Index; CHQ, Child Health Questionnaire; HRQOL, health-related quality of life; PhS, physical summary; PsS, psychosocial summary; sJIA, systemic juvenile idiopathic arthritis; VAS visual analog scale